Posted by Wes Hall, Amy Freedman, and Ian Robertson, Kingsdale Advisors, on Friday, June 21, 2019 Tags: Boards of Directors, Canada, Commodities, International governance, Proxy contests, Shareholder activism, Shareholder value Statement on the Adoption of Capital, Margin, and Segregation Requirements for Security-Based Swap Dealers and Major Security-Based Swap Participants Posted by Hester M. [read post]

Rachel E. [read post]

Simon; JD 2000 University of California Berkeley; Teaching Fellow Stanford Research Fellow Stanford; United States District Court; Patents, Intellectual Property Tulane University Amy Stein; JD 2000 University of Chicago; Visiting Associate Professor of Legal Research and Writing George Washington University; Environmental Law University of Akron Ryan Vacca; JD 2004 University of Missouri; LL.M. 2008 New York University Trade Regulation/Intellectual Property; VAP University of Oregon, VAP University… [read post]

Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]